Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 18, 2004

View Archived Issues

Antiangiogenic small molecule inhibits VEGF production in tumors in vivo

Turmeric extract prevents arthritis in rat model

Pharmacokinetic profile of novel bone resorption inhibitor

Nucleotide-bisphosphonate conjugates reduce metastatic bone tumor burden in mice

Novel vasopressin V1a receptor antagonists and their use in dysmenorrhea

New analgesic vanilloid VR1 antagonists discovered at Merck

Antagonists of denatured collagen type IV and their use as antiangiogenic agents

Novel PPAR agonists and their use described by Pfizer researchers

Neurogen presents novel GABA-A receptor modulators

New benzofurans acting as 5-HT reuptake inhibitors and 5-HT receptor ligands

New indole-containing oxazolidinone antibacterial agents identified at Pfizer

Highlights from the 4th Annual Biotech In Europe Investor Forum now available at LifeSciChannel.com

Anecortave acetate study results

R&D highlights from the 4th Annual Biotech In Europe Investor Forum: BioTie Therapies

ArQule discovers oral B-RAF kinase inhibitors for oncology

CuraGen advances CR-011 for metastatic melanoma

Cerovive phase III trials to continue

Visudyne VIO study recommended to continue

IND submission for Syrrx-designed DPP IV inhibitor for diabetes

Enrollment opens in phase II study of MX-3253

JuvImmune platform to be tested in PuntaToro virus infection model

Patients receive HGS-ETR1 in new cancer studies

AGIX-4207 discontinued for rheumatoid arthritis after disappointing results

Pivotal PolyHeme study cleared to continue

R&D highlights from the 4th Annual Biotech In Europe Investor Forum: BioXell

Vantas approved for advanced prostate cancer

Government funding for Elusys' development of anthrax antibody treatment

Abarelix demonstrates safety and efficacy in clinical trials

New data on the antimicrobial activity and pharmacokinetics of tigecycline

HepeX-C reduces viral levels in patients with chronic HCV infection

Bone turnover has no effect on the benefits of teriparatide in women with osteoporosis

Update on the pharmacokinetic profile of a transdermal PTH formulation

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...